REG - Eden Research plc - Result of AGM

Eden ResearchAnnouncement

30/06/2021 12:05

RNS Number : 6626D
  
Eden Research plc
  
30 June 2021
  
 

30 June 2021
 
Eden Research Plc
("Eden" or "Company")
 
Result of AGM 
 
Eden Research plc (AIM: EDEN), the AIM-quoted company focused on sustainable biopesticides and plastic-free formulation technology for use in the global crop protection, animal health and consumer products industries, is pleased to announce that, at the Annual General Meeting ("AGM") of Eden held today at 12.00pm at 67C Innovation Drive, Milton Park, Abingdon, Oxfordshire, OX14 4RQ, all the resolutions were duly passed. 
For further information contact:



 
Eden Research plc


www.edenresearch.com




Sean Smith

Alex Abrey


01285 359 555




 
Cenkos Securities plc (Nominated advisor and broker)








Giles Balleny / Camilla Hume/ Mark Connelly  (corporate finance)

Michael Johnson (sales)


020 7397 8900




 
Hawthorn Advisors (Financial PR)








Lorna Cobbett / Victoria Ainsworth


eden@hawthornadvisors.com



 
 
 
 
Notes to Editors:
 
Eden Research is an AIM quoted company that develops and supplies breakthrough biopesticide products and natural, plastic-free microencapsulation technologies to the global crop protection, animal health and consumer products industries.
 
Eden's Sustaine® encapsulation technology is used to harness the biocidal efficacy of naturally occurring chemicals produced by plants (terpenes) and can also be used with both natural and synthetic compounds to enhance their performance and ease-of-use. Sustaine microcapsules are naturally-derived, plastic-free, biodegradable micro-spheres derived from yeast. It is one of the only viable, proven and immediately registerable solutions to the microplastics problem in formulations requiring encapsulation.
 
Eden has numerous patents and a pipeline of products at differing stages of development targeting specific areas of the global agrochemicals industry. Eden was admitted to trading on AIM in May 2012.
 
For more information about Eden, please visit: www.edenresearch.com.
 
ENDS

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
  END
 
 
RAGFMMMTMTBJBAB